TIDES USA 2023
KACTUS will be exhibiting at TIDES San Diego at booth #816. Stop by our booth...
Apr 24, 2023
Full Portfolio of In Vitro mRNA Synthesis Enzymes Submitted to FDA Drug Master Files (DMF)
Contact us to request a quote or test sample! Following the filings of our...
Apr 23, 2023
Bringing Innovative Biotechnology to the BVS Innovation Symposium
BVS Innovation Symposium April 27th, 2023, 4-8pm Le Méridien Boston Cambridge20 Sydney St, Cambridge, MA 02139...
Apr 18, 2023
Festival of Biologics 2023
MEET KACTUS AT THE FESTIVAL OF BIOLOGICS 2023. San Diego, CA March 20-22 Booth...
Mar 15, 2023
New target for colorectal cancer: GPA33
Colorectal cancer (CRC) is the third most common tumor and the most common tumor of...
Feb 24, 2023
Potential drug target for tumors: CDCP1
The process of tumor cell infiltration, adhesion and migration is an important research direction in...
Feb 21, 2023
Cell and antibody therapies targeting HLA-G
On December 19, 2022, the FDA approved the Phase I/IIa clinical trial application of IVS-3001,...
Feb 14, 2023
